重组骨保护素,rhOPG
1)rhOPG重组骨保护素
2)osteoprotegerin(OPG)骨保护素
1.Objective:To study the expression of IL-10 at protein level in human dental follicle cells(HDFCs)and the effect of IL-10 on osteoprotegerin(OPG) secretion.目的:研究人牙囊细胞白细胞介素-10(IL-10)蛋白的表达及其对骨保护素(osteoprotegerin,OPG)表达的影响。
2.In addition,the Semiquantitative RT-PCR was using to assessed the regulation of dexamethasone(DEX)for Osteoprotegerin(OPG)or Ligand of receptor activator of nuclear factor kappa B(RANKL)in FRS.采用MTT掺入法检测细胞活率变化,分别筛选出诱导细胞增殖与凋亡的药物浓度;半定量PCR法检测不同浓度下地塞米松对骨保护素(Osteoprotegerin,OPG)和核因子κB受体激活剂受体配体(Ligand of receptor activator of nuclear factor kappa B,RANKL)基因在mRNA水平上的调控作用;流式细胞术检测细胞周期分布和凋亡率变化,显微镜观察FRSs存活、增殖和凋亡变化。
3.Objective To study the expression and significance of osteoprotegerin(OPG)in the development of dogs permanent teeth germs.目的:探讨犬乳恒牙替换过程中骨保护素在犬恒牙胚发育中的表达及意义。
英文短句/例句

1.A Study on the Expression of Osteoprotegerin during the Replacement of Dog s Primary and Permanent Teeth;犬乳恒牙替换期骨保护素表达的研究
2.Experimental Study of the Osteoprotegerin and the Ovariectomized Rat Model of Osteoporosis;骨保护素与去卵巢大鼠骨质疏松模型实验研究
3.Relationship between Serum Osteoprotegerin Level and Osteoporosis of Type 2 Ddiabetes Patients2型糖尿病患者骨保护素与骨质疏松的关系
4.OSTEOPROTEGRIN AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND mRNAs EXPRESSION IN BMSCs OF GLUCOCORTICOID-INDUCED NECROSIS OF THE FEMORAL HEAD PATIENTS激素性股骨头坏死BMSCs骨保护素/NF-κB受体活化因子配基mRNA的表达
5.The Protective Effect of Osteprotegerin on the Joints of Adjuvant-induced Arthritic Rats and Its Possible Mechanism;骨保护素对佐剂性关节炎大鼠关节保护作用及可能机制
6.Case-control Study on Association between Osteoprotegerin Gene Polymorphism and Coronary Heart Disease;骨保护素基因多态性与冠心病病例—对照研究
7.Construction and Primary Expression of Human Osteoprotegerin in Mammalian Vectors;人骨保护素哺乳类表达载体的构建及初步表达
8.Study on the Relationship between Serum Level of Osteoprotegerin and Coronary Heart Disease;血清骨保护素水平与冠状动脉病变关系的研究
9.Progress in Research of Osteoprotegerin System in Vascular Diseases骨保护素系统在血管疾病中的研究进展
10.The clinical value of serum osteoprotegerin level in the diagnosis of lung cancer血清骨保护素在肺癌诊断中的临床价值
11.Inhibitory Effect of Plasmid Delivery of Osteoprotegerin on Alveolar Bone Resorption Resulting from Experimental Periodontitis in Rats;人骨保护素质粒转染抑制大鼠实验性牙周炎骨吸收的研究
12.Study of ex vivo OPG Gene Therapy in Preventing Wear Debris Induced Osteolysis;人骨保护素基因治疗抑制磨损颗粒诱导骨溶解的实验研究
13.The Efects of Recombinant Human Osteoprotegerin on the Osteoclasts Indueced by the Polyethylene Particles;重组人骨保护素对聚乙烯颗粒刺激破骨细胞功能的影响
14.The Culture and Identification of Rat MSC Cell Lines Modified by Osteoprotegerin Gene;骨保护素基因修饰的大鼠骨髓基质细胞系的培养、表达与鉴定
15.The Study of Relationship between Serum Osteoprotegerin Level and Renal Osteodystrophy in Maintenance Hemodialysis Patients;维持性血液透析患者血清骨保护素与肾性骨病关系的研究
16.Effects of Resveratrol on Osteoprotegerin and Osteoprotegerin Ligand Expression of Femurs in Ovariectomized Rats;白藜芦醇对去卵巢大鼠股骨骨保护素及其配体表达的影响
17.The clone of OPG and its effects on the differentiation of bome morrow stem cells骨保护素的克隆及对骨髓间充质干细胞分化的影响
18.Effects of osteoprotegerin on osteoclasts in the occlusal tissue during tooth eruption in dog骨保护素对犬牙齿萌出过程中方组织内破骨细胞的影响
相关短句/例句

osteoprotegerin(OPG)骨保护素
1.Objective:To study the expression of IL-10 at protein level in human dental follicle cells(HDFCs)and the effect of IL-10 on osteoprotegerin(OPG) secretion.目的:研究人牙囊细胞白细胞介素-10(IL-10)蛋白的表达及其对骨保护素(osteoprotegerin,OPG)表达的影响。
2.In addition,the Semiquantitative RT-PCR was using to assessed the regulation of dexamethasone(DEX)for Osteoprotegerin(OPG)or Ligand of receptor activator of nuclear factor kappa B(RANKL)in FRS.采用MTT掺入法检测细胞活率变化,分别筛选出诱导细胞增殖与凋亡的药物浓度;半定量PCR法检测不同浓度下地塞米松对骨保护素(Osteoprotegerin,OPG)和核因子κB受体激活剂受体配体(Ligand of receptor activator of nuclear factor kappa B,RANKL)基因在mRNA水平上的调控作用;流式细胞术检测细胞周期分布和凋亡率变化,显微镜观察FRSs存活、增殖和凋亡变化。
3.Objective To study the expression and significance of osteoprotegerin(OPG)in the development of dogs permanent teeth germs.目的:探讨犬乳恒牙替换过程中骨保护素在犬恒牙胚发育中的表达及意义。
3)osteoprotegerin骨保护素
1.Effect of advanced glycation end-products on the gene expression of osteoprotegerin in cultured rat vascular smooth muscle cells;糖基化终产物对大鼠血管平滑肌细胞骨保护素mRNA表达的影响
2.Effects of resveratrol on the expression of osteoprotegerin and receptor activator for NF-κB ligand in femurs of ovariectomized rats;白藜芦醇对去卵巢大鼠股骨骨保护素及核因子κB受体活化子配体表达的影响
3.The mechanism of osteoprotegerin on mineralization of enamel;骨保护素及其在釉质矿化中的作用机制
4)OPG骨保护素
1.Study of the PKA and PKC Signal Transduction Pathway of Regulation of OPG and RANKL mRNA Expression by hPTH(1-34);人甲状旁腺激素调节骨保护素及其配体基因表达的PKA、PKC信号传导通路研究
2.Effect of rhIGF-1 on the proliferation and differentiation and OPG,RANKL gene expression in rat osteoblast;rhIGF-1对成骨细胞增殖、分化及骨保护素、骨保护素配体基因mRNA表达的影响
3.Effects of cobalt and chromium ions on osteoblasts:cytotoxicity and the releasion of RANKL and OPG钴铬离子对成骨细胞细胞毒性及对其分泌骨保护素及其配体的影响
5)OPG骨保护素(OPG)
6)osteoprotegerin骨保护素(OPG)
延伸阅读

诺德人体生长激素,基因重组人生长激素,健高买,重组人生长激素药物名称:重组人生长激素英文名:Somatropin别名:诺德人体生长激素,基因重组人生长激素,健高买,重组人生长激素外文名:Saizen, Norditropin, Genotropin, Norditropin, DNA-rhGH药理作用:为DNA重组技术生产的人体生长激素,是促进生长的机制之一,能刺激IGF-1和蛋白质合成,促进骨骼和体细胞的生长,利于脂肪分解和蛋白质合成,使肌肉增加,脂肪减少.适应症:用于内源性生长激素分泌不足或先天性性腺发育不全(特纳综合征)所引起的生长发育障碍,青春期前慢性肾功能不全所引起的生长发育障碍,成人生长激素不足的替代疗法(用于心功能不全等).注意点:1.配制药液时不可振荡,以免变性.2.每周剂量分7天皮下注射,注射部位应更换,如有一天漏注,则第二天不必倍量补注。3.糖尿病、妊娠、乳母慎用。4.恶性肿瘤术后,对本品过敏者,各种活动性恶性肿瘤禁用。5.不良反应可能会有甲状腺功能减退,液体潴留、伴周围水肿,曾有少数良性颅内高压病例的报告。用量用法:成人:生长激素不足:0.125iu/(kg.周) 。 先天性子宫发育不全: 1iu/(kg.周),以上剂量均分作7天皮下注射。规格:针剂:4iu, 10iu, 12iu, 16iu.类别:生殖系统药/促进子宫成熟药